Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yau Wei Ooi"'
Autor:
Chiam, Paul Toon Lim, Nien Shen Chan, Yean Teng Lim, Choon Pin Lim, Nair, Dinesh, Tai Tian Lim, Chao Yang Soon, Chung Hoe Khoo, Brian, Lim, Jimmy, Kok Soon Tan, Lam, Leslie, Yan, Peter, Yau Wei Ooi, Mei Sian Chong, Chan, Nien Shen, Lim, Yean Teng, Lim, Choon Pin, Lim, Tai Tian, Soon, Chao Yang, Khoo, Brian Chung Hoe
Publikováno v:
Singapore Medical Journal; May2022, Vol. 63 Issue 5, p268-273, 6p
Autor:
Thuzar Tint Nyein, Fahim Haider Jafary, Dasdo Antonius Sinaga, Jason Kwok Kong Loh, Alyssa Sim, Hee Hwa Ho, Timothy James Watson, Paul Jau Lueng Ong, Yau Wei Ooi, Julian K.B. Tan
Publikováno v:
Journal of Interventional Cardiology. 29:454-460
Background Drug-coated balloons (DCB) have been used to treat de novo small vessel coronary disease (SVD), with promising results and shorter dual antiplatelet therapy (DAPT) duration compared to drug-eluting stents (DES). We compared safety and effe
Autor:
Yau Wei Ooi, Than Htike Aung, Fahim Haider Jafary, Julian Tan, Paul Jau Lueng Ong, Hee Hwa Ho, Kwok Kong Loh
Publikováno v:
International Journal of Cardiology. Heart & Vessels
Background Drug eluting balloon (DEB) is a new therapeutic option for treatment of obstructive coronary lesions in percutaneous coronary intervention (PCI). There is limited data on the safety and efficacy of DEB in Asian patients in contemporary cli
Autor:
Leonardo Carvalho, Peter A. McCullough, Ling Ling Sim, Huay-Cheem Tan, David Foo, Yau Wei Ooi, Tiong-Cheng Yeo, Mark Y. Chan, A. Mark Richards, Fei Gao
Publikováno v:
International Journal of Cardiology. 168:1397-1401
Impaired renal function and anaemia are common among patients with acute myocardial infarction (AMI). While both conditions are known independent risk factors for increased mortality, their interaction as risk factors for increased mortality in AMI i
Autor:
Dasdo Antonius, Sinaga, Hee Hwa, Ho, Timothy James, Watson, Alyssa, Sim, Thuzar Tint, Nyein, Fahim H, Jafary, Jason K K, Loh, Yau Wei, Ooi, Julian K B, Tan, Paul J L, Ong
Publikováno v:
Journal of interventional cardiology. 29(5)
Drug-coated balloons (DCB) have been used to treat de novo small vessel coronary disease (SVD), with promising results and shorter dual antiplatelet therapy (DAPT) duration compared to drug-eluting stents (DES). We compared safety and effectiveness o
Publikováno v:
Journal of Interventional Cardiology. 24:315-319
We describe 2 cases of complex coronary lesions in which the conventional 0.014-inch balloon catheters failed to cross a chronic subtotal occlusion and also failed to adequately predilate a calcified coronary lesion. The novel use of a 0.010-inch gui
Autor:
Paul Jau Lueng Ong, Uwe Zeymer, Hee Hwa Ho, Matthias Waliszewski, Julian K.B. Tan, Fahim Haider Jafary, Yau Wei Ooi, Jason Kwok Kong Loh, Dasdo Antonius Sinaga
Publikováno v:
Therapeutic advances in cardiovascular disease. 9(6)
Background: Coronary angioplasty in advanced age is associated with higher rate of comorbidities and complications. Drug coated balloon only angioplasty (DCBA) has emerged as an alternative to treat small vessel coronary disease (SVCD), of reference
Autor:
Julian K.B. Tan, Dasdo Antonius Sinaga, Fahim Haider Jafary, Hee Hwa Ho, Paul Jau Lueng Ong, Yau Wei Ooi, Jason Kwok Kong Loh
Publikováno v:
Journal of the American College of Cardiology. 65(17)
Autor:
Than Htike Aung, Fahim Haider Jafary, Kwok Kong Loh, Hee Hwa Ho, Yau Wei Ooi, Dasdo Antonius Sinaga, Nwe Tun Yin, Julian Tan, Paul Jau Lueng Ong
Publikováno v:
World journal of cardiology. 7(6)
We evaluated the clinical feasibility of using drug-coated balloon (DCB) angioplasty in patients undergoing primary percutaneous coronary intervention (PPCI). Between January 2010 to September 2014, 89 ST-elevation myocardial infarction patients (83%
Autor:
Hee Hwa, Ho, Fahim Haider, Jafary, Kwok Kong, Loh, Julian Ko Beng, Tan, Yau Wei, Ooi, Paul Jau Lueng, Ong
Publikováno v:
The Journal of invasive cardiology. 24(12)
Stent delivery failure occurs in 4% of all percutaneous coronary interventions (PCIs) and90% of these failures are due to vessel tortuosity and/or calcification. Stent performance of the newly launched Integrity coronary stent has markedly improved d